Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1B, Multiple Ascending Dose Trial Examining The Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects

NCT05247528 is registered in ClinicalTrials.gov with E-Star BioTech, LLC as lead sponsor.

NCT NCT05247528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05247528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1B, Multiple Ascending Dose Trial Examining The Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects
Lead sponsor
E-Star BioTech, LLC
Phase
Phase 1
Overall status
Completed
Start date
December 20, 2021
Completion date
October 31, 2022
Enrollment
37 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

difficult to control hypertension, resistant hypertension